AIA
GSK icon

AIMZ Investment Advisors’s GSK GSK Stock Holding History

AIMZ Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Sell
59,214
-120
-0.2% -$6.35K 0.85% 37
2026
Q1 		$3.27M Sell
59,334
-1,489
-2% -$80.7K 1.01% 34
2025
Q4 		$2.98M Sell
60,823
-397
-0.6% -$18.5K 0.85% 36
2025
Q3 		$2.64M Sell
61,220
-647
-1% -$25.3K 0.83% 39
2025
Q2 		$2.38M Sell
61,867
-392
-0.6% -$15K 0.8% 41
2025
Q1 		$2.41M Sell
62,259
-272
-0.4% -$9.96K 0.84% 41
2024
Q4 		$2.11M Buy
62,531
+666
+1% +$24K 0.73% 43
2024
Q3 		$2.53M Sell
61,865
-474
-0.8% -$19.4K 0.86% 35
2024
Q2 		$2.4M Sell
62,339
-593
-0.9% -$24.9K 0.86% 36
2024
Q1 		$2.7M Sell
62,932
-1,195
-2% -$49.3K 1.01% 35
2023
Q4 		$2.38M Sell
64,127
-554
-0.9% -$19.9K 0.96% 36
2023
Q3 		$2.34M Sell
64,681
-734
-1% -$26.1K 1.04% 34
2023
Q2 		$2.33M Buy
65,415
+6
+0% +$215 1% 36
2023
Q1 		$2.33M Sell
65,409
-542
-0.8% -$19K 1.04% 37
2022
Q4 		$2.32M Sell
65,951
-7,113
-10% -$237K 1.09% 36
2022
Q3 		$2.15M Buy
+73,064
New +$2.77M 1.09% 36
2022
Q2 		– Sell
-74,426
Closed -$4.05M – 112
2022
Q1 		$4.05M Sell
74,426
-3,021
-4% -$164K 1.67% 17
2021
Q4 		$4.27M Buy
77,447
+1,848
+2% +$96.1K 1.66% 15
2021
Q3 		$3.61M Buy
75,599
+1,367
+2% +$68.7K 1.63% 16
2021
Q2 		$3.69M Buy
74,232
+490
+0.7% +$23.5K 1.66% 16
2021
Q1 		$3.29M Buy
73,742
+54
+0.1% +$2.45K 1.61% 19
2020
Q4 		$3.39M Sell
73,688
-400
-0.5% -$18.4K 1.78% 17
2020
Q3 		$3.49M Buy
+74,088
New +$3.71M 2.09% 13

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AIMZ Investment Advisors's GSK Position: Q2 2026 in Review

AIMZ Investment Advisors reduced its GSK (GSK) stake by 0.2% in Q2 2026, selling an estimated $6.35K and leaving 59,214 shares worth $3.1M. The position accounts for 0.85% of the portfolio, ranked #37.

AIMZ Investment Advisors first reported a position in GSK in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.27M in Q4 2021. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • AIMZ Investment Advisors held 59,214 shares of GSK worth $3.1M as of Q2 2026.
  • AIMZ Investment Advisors sold 120 GSK shares in Q2 2026, an estimated $6.35K.
  • GSK made up 0.85% of AIMZ Investment Advisors's portfolio in Q2 2026, its #37 holding.
  • AIMZ Investment Advisors first reported a position in GSK in Q3 2020 and has held it in 23 quarters since.
  • AIMZ Investment Advisors's GSK position peaked at $4.27M in Q4 2021.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.